Harmony Biosciences Holdings (HRMY) Deferred Taxes (2022 - 2025)
Historic Deferred Taxes for Harmony Biosciences Holdings (HRMY) over the last 4 years, with Q3 2025 value amounting to -$3.9 million.
- Harmony Biosciences Holdings' Deferred Taxes rose 1964.8% to -$3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$21.4 million, marking a year-over-year increase of 34.48%. This contributed to the annual value of -$29.3 million for FY2024, which is 11833.22% down from last year.
- Latest data reveals that Harmony Biosciences Holdings reported Deferred Taxes of -$3.9 million as of Q3 2025, which was up 1964.8% from -$6.5 million recorded in Q2 2025.
- In the past 5 years, Harmony Biosciences Holdings' Deferred Taxes ranged from a high of $1.1 million in Q4 2023 and a low of -$14.3 million during Q2 2024
- Its 4-year average for Deferred Taxes is -$5.1 million, with a median of -$4.3 million in 2022.
- In the last 5 years, Harmony Biosciences Holdings' Deferred Taxes soared by 12633.68% in 2023 and then plummeted by 69768.48% in 2024.
- Harmony Biosciences Holdings' Deferred Taxes (Quarter) stood at -$4.3 million in 2022, then surged by 126.34% to $1.1 million in 2023, then tumbled by 697.68% to -$6.7 million in 2024, then soared by 42.18% to -$3.9 million in 2025.
- Its Deferred Taxes was -$3.9 million in Q3 2025, compared to -$6.5 million in Q2 2025 and -$4.3 million in Q1 2025.